Targeting TAT-hOGG1 into Mitochondria as a Therapeutic Strategy for Breast Cancer Progression

被引:0
|
作者
Yuzefovych, Larysa [1 ]
Pastukh, Viktor [1 ]
Kahn, Andrea [2 ]
Rachek, Lyudmila [1 ]
机构
[1] Univ S Alabama, Coll Med, Mobile, AL USA
[2] Univ Alabama Birmingham, Birmingham, AL USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1169
引用
收藏
页码:1267 / 1267
页数:1
相关论文
共 50 条
  • [1] Targeting TAT-hOGG1 into Mitochondria as a Therapeutic Strategy for Breast Cancer Progression
    Yuzefovych, Larysa
    Pastukh, Viktor
    Kahn, Andrea
    Rachek, Lyudmila
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1267 - 1267
  • [3] Targeting mitochondria as a potential therapeutic strategy against chemoresistance in cancer
    Mukherjee, Soumi
    Bhatti, Gurjit Kaur
    Chhabra, Ravindresh
    Reddy, P. Hemachandra
    Bhatti, Jasvinder Singh
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 160
  • [4] Targeting mitochondria as a novel therapeutic strategy in biliary tract cancer
    Carotenuto, P.
    Barbato, A.
    Indrieri, A.
    Volpe, M.
    Quadrano, P.
    Brillante, S.
    Riccardo, S.
    Mirante, L.
    Cacchiarelli, D.
    Antonella, I.
    Franco, B.
    Salatiello, M.
    Troncone, G.
    Bonetti, L. Reggiani
    Dominici, M.
    Salati, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S269 - S269
  • [5] Targeting mitochondria emerges as therapeutic strategy
    Garber, K
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (24) : 1800 - 1801
  • [6] Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancer
    Morisaki, T
    Katano, M
    CURRENT MEDICINAL CHEMISTRY, 2003, 10 (23) : 2517 - 2521
  • [7] Targeting breast cancer stem cells as a therapeutic strategy
    Clarkson, Richard
    BREAST CANCER MANAGEMENT, 2014, 3 (03) : 237 - 240
  • [8] Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy
    Dong, Haonan
    Zhang, Lu
    Liu, Suling
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (08): : 3421 - 3434
  • [9] Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer
    Wedam, Rohan
    Greer, Yoshimi Endo
    Wisniewski, David J.
    Weltz, Sarah
    Kundu, Manjari
    Voeller, Donna
    Lipkowitz, Stanley
    CANCERS, 2023, 15 (07)
  • [10] Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
    Cortez, Valerie
    Mann, Monica
    Tekmal, Seshidhar
    Suzuki, Takayoshi
    Miyata, Naoki
    Rodriguez-Aguayo, Cristian
    Lopez-Berestein, Gabriel
    Sood, Anil K.
    Vadlamudi, Ratna K.
    BREAST CANCER RESEARCH, 2012, 14 (04):